SYMBICORT is available in two dosing strengths
SYMBICORT pMDI is a combination of budesonide and formoterol, available in 2
strengths:
-
80/4.5 (80 mcg budesonide, 4.5 mcg formoterol)
-
160/4.5 (160 mcg budesonide, 4.5 mcg formoterol)
Prescription SYMBICORT is for patients
-
Not adequately controlled on other asthma-controller medications (eg, low- to
medium dose inhaled corticosteroids)
-
Whose disease severity clearly warrants initiation of two maintenance therapies
For all patients, consideration should be given to titrating to the lowest
effective strength after adequate asthma stability has been achieved.

-
The maximum daily recommended dose is 640/18 mcg budesonide/formoterol (given
as 2 inhalations of SYMBICORT 160/4.5 twice daily) for patients 12 years and
older. Do not use more than twice daily or use a higher number of inhalations
(more than 2 inhalations twice daily) of the prescribed strength of SYMBICORT
as this will result in a daily dose of formoterol in excess of the dose
determined to be safe. For all patients, consideration should be given to
titrating to the lowest effective strength after adequate asthma stability has
been achieved
-
Patients who are receiving SYMBICORT should not use additional formoterol or
other long-acting beta2-agonists for any reason
